Pacira Biosciences, Inc. (PCRX) fundamentals score
Pacira , EXPAREL , ZILRETTA , iovera °, the Pacira logo and other trademarks or service marks of Pacira appearing in this Annual Report are the property of Pacira, and when first used in each part of this Annual Report, include the symbol.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 6.9 out of 10, Mixed fundamentals
- Growth: 6.0/10
- Profitability: 6.6/10
- Financial health: 7.4/10
- Earnings quality: 9.3/10
- Valuation: 6.0/10
Scores are calculated from Pacira Biosciences, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10